CLOSE

LAWYERS

SEARCH BY ALPHABETICAL ORDER

SEE ALL LAWYERS
CLOSE

PRACTICE AREAS

Life Sciences Newsletter – July 2022

LIFE SCIENCES NEWSLETTER

MINSA

HEALTH FACILITIES: CULTURAL IDENTIFICATION AND SIGNAGE

Ministerial Resolution Nº 527-2022/MINSA establishes that the identification and signage of health facilities at the first level of care with cultural relevance -which have indigenous, Amazonian, Andean and/or Afro-descendant populations within their scope- must have colors, pictograms and cultural characteristics particular to these populations.

PERU COMPRAS

PHARMACEUTICAL PRODUCTS: TECHNICAL DATA SHEETS

By Head Resolution Nº 000087-2022-PERÚ COMPRAS-JEFATURA, 133 technical data sheets of the item Medicines and pharmaceutical products of the List of Common Goods and Services were modified. The technical data sheets can be found at the following link: www.perucompras.gob.pe/lbsc.

MINSA

HEALTHY FOOD: DRAFT TECHNICAL PARAMETERS

Ministerial Resolution No. 526-2022/MINSA updates the technical parameters for the application of advertising warnings regarding the sugar, sodium and saturated fat content of processed foods. The draft proposes the modification of the Regulation of the Healthy Food Law. The bill mainly points out the following:

  • Eliminates infant foods and special diets of the Codex Alimentarius, including breast milk substitutes, within the exceptions from the application of the octagons.
  • Modifies the definition of “sugars”.
  • Updates the technical parameters to stricter amounts of sodium, sugar and saturated fats in processed foods and beverages.
  • Establishes specific sodium, sugar and saturated fat parameters for breast milk substitutes and infant foods.

Comments shall be received during the 90 calendar day period through the following e-mail: webmaster@minsa.gob.pe.

CONGRESS

BILL: CONSTITUTIONAL REFORM OF THE RIGHT TO HEALTH CARE

Bill Nº 2551-2021-CR proposes that the State invest annually not less than 7% of the GDP in health. Likewise, it is proposed that the State must have the use of all medical-care resources of the public and private sectors in the context of a health emergency.

DIGEMID

INSPECTIONS FOR THE CERTIFICATION OF GOOD MANUFACTURING PRACTICES OF FOREIGN LABORATORIES

  1. Ministerial Resolution Nº 513-2022/MINSA authorizes Digemid to travel to Argentina from July 17 to 23, 2022 to carry out inspections in order to grant Good Manufacturing Practices Certification to laboratories engaged in the manufacture of pharmaceuticals, and medical devices.
  1. Ministerial Resolution No. 514-2022/MINSA authorizes Digemid to travel to Mexico from July 17 to 23, 2022 to conduct inspections in order to grant the Good Manufacturing Practices Certification to laboratories engaged in the manufacture of pharmaceuticals, and medical devices.
  1. Ministerial Resolution Nº 515-2022/MINSA authorizes Digemid to travel to Chile from July 17 to 23, 2022 to carry out inspections in order to grant the Good Manufacturing Practices Certification to laboratories engaged in the manufacture of pharmaceutical products, medical devices and health products.
  1. Ministerial Resolution Nº 516-2022/MINSA authorizes Digemid to travel to Venezuela from July 17 to 23, 2022 to conduct inspections in order to grant the Good Manufacturing Practices Certification to laboratories engaged in the manufacture of pharmaceuticals, and medical devices.
  1. Ministerial Resolution Nº 495-2022/MINSA authorizes Digemid to travel to Colombia from July 10 to 16, 2022 to conduct inspections in order to grant the Good Manufacturing Practices Certification to laboratories engaged in the manufacture of pharmaceuticals, and medical devices.
  1. Ministerial Resolution Nº 496-2022/MINSA authorizes Digemid to travel to Mexico from July 17 to 23, 2022 to conduct inspections in order to grant Good Manufacturing Practices Certification to laboratories engaged in the manufacture of pharmaceuticals, and medical devices.
  1. Ministerial Resolution Nº 560-2022/MINSA authorizes Digemid to travel to Ecuador from July 31 to August 6, 2022 to conduct inspections in order to grant the Good Manufacturing Practices Certification to laboratories engaged in the manufacture of pharmaceuticals, and medical devices.

SUNAT

REMITTANCE ADVICES AND ELECTRONIC ISSUERS

By Superintendence Resolution Nº 000123-2022/SUNAT, several provisions on remittance advices are modified in order to adopt their electronic issuance as a general rule. The main modifications are the following: they incorporate new requirements to facilitate controls, establish the electronic documents that support the transfer of goods and designate the subjects that acquire the quality of electronic issuers of remittance advices. This regulation may be of interest to drugstores when issuing waybills for the commercialization and storage of pharmaceuticals, medical devices and health products.

DIGEMID/DIGESA

IMPORT AND EXPORT MEASURES AND FACILITIES FOR OAS

Supreme Decree Nº 013-2022-SA establishes import and export measures and facilities for companies certified as Authorized Economic Operators (AEO) for products regulated by DIGEMID and DIGESA.

DIGEMID

ADDITIONAL DEADLINES TO SUPPORT SAFETY AND EFFICACY

By Supreme Decree Nº 012-2022-SA additional deadlines are granted to support the safety and efficacy of pharmaceutical specialties included in Supreme Decree Nº 016-2013-SA. The new deadlines are:

For cases of Deadline
1 Reformulation Up to 6 months
2 Clinical studies Up to 2 years

MINSA

MANUAL OF GOOD PHARMACEUTICAL OFFICE PRACTICES

Ministerial Resolution Nº 554-2022/MINSA adopts the Technical Document: Manual of Good Pharmaceutical Office Practices, which establishes technical criteria and health conditions to be met by pharmacies, drugstores and pharmacies of health facilities. Thus, the Manual of Good Storage Practices for Pharmaceutical and Related Products, adopted by Ministerial Resolution Nº 585-99-SA/DM, and the Manual of Good Dispensing Practices, adopted by Ministerial Resolution Nº 013-2009/MINSA, are no longer in effect.

DIGEMID

NEW DIRECTOR GENERAL OF DIGEMID

Ministerial Resolution Nº 504-2022/MINSA appoints pharmaceutical chemist Lida Esther Hildebrandt Pinedo as the new Director General of Digemid.

DIGEMID

REGULATION REGULATING THE PURCHASE OF VACCINES AND MEDICINES AGAINST COVID-19

Supreme Decree Nº 014-2022-SA adopts the Regulation of Law 31225. The Regulation exceptionally authorizes regional governments, local governments or private companies to purchase the doses. Thus, it seeks to ensure the quality, safety and efficacy of vaccines and drugs against Covid-19 that have conditional health registration, imported or acquired by private companies, regional governments or local governments.

DIGESA

HEALTH STANDARD ON THE MANUFACTURE OF HIGH RISK HANDCRAFT PRODUCTS

Ministerial Resolution Nº 523-2022/MINSA publishes the draft Technical Health Standard “Health Standard for the implementation of the Integrated Production System in the elaboration of high risk artisanal dairy products”. Digemid shall receive comments until Wednesday, August 3, 2022 via email: webmaster@minsa.gob.pe.

DIGEMID

DOCUMENTS FOR REGISTRATION OF BIOLOGICAL PRODUCTS

Ministerial Resolution Nº  563-2022/MINSA publishes draft Regulation that regulates the presentation and content of the documents required for the registration and re-registration of biological products: Other biological products. The Regulation establishes the rules that regulate the presentation of such documents and the information that such documents must contain. Comments shall be received during a period of 90 calendar days via e-mail: webmaster@minsa.gob